Linda Marban
CHIEF EXECUTIVE OFFICER at Capricor Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Capricor Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Capricor Therapeutics Inc. June 4, 202682.8%
-
Capricor Therapeutics Inc. May 22, 202597.1%
-
Capricor Therapeutics Inc. May 14, 202483.4%
-
Capricor Therapeutics Inc. June 12, 202384.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2025 | Capricor Therapeutics Inc. | Other | −12,500 | — | — |
| Mar 3, 2025 | Capricor Therapeutics Inc. | Option exercise | +25,000 | $1.39 | $34,750 |
| May 12, 2023 | Capricor Therapeutics Inc. | Option exercise | +20,749 | $1.39 | $28,841 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.